Cargando…
Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
The presence of insoluble aggregates of amyloid β (Aβ) in the form of neuritic plaques (NPs) is one of the main features that define Alzheimer’s disease. Studies have suggested that the accumulation of these peptides in the brain significantly contributes to extensive neuronal loss. Furthermore, the...
Autores principales: | Campos-Peña, Victoria, Pichardo-Rojas, Pavel, Sánchez-Barbosa, Talía, Ortíz-Islas, Emma, Rodríguez-Pérez, Citlali Ekaterina, Montes, Pedro, Ramos-Palacios, Gerardo, Silva-Adaya, Daniela, Valencia-Quintana, Rafael, Cerna-Cortes, Jorge Francisco, Toral-Rios, Danira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603563/ https://www.ncbi.nlm.nih.gov/pubmed/36292947 http://dx.doi.org/10.3390/ijms232012092 |
Ejemplares similares
-
GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
por: Toral-Rios, Danira, et al.
Publicado: (2020) -
Early Onset Alzheimer's Disease and Oxidative Stress
por: Meraz-Ríos, Marco Antonio, et al.
Publicado: (2014) -
SORL1 Polymorphisms in Mexican Patients with Alzheimer’s Disease
por: Toral-Rios, Danira, et al.
Publicado: (2022) -
Oxidative Stress and Metabolic Syndrome: Cause or Consequence of Alzheimer's Disease?
por: Luque-Contreras, Diana, et al.
Publicado: (2014) -
Inflammatory process in Alzheimer's Disease
por: Meraz-Ríos, Marco A., et al.
Publicado: (2013)